Logo image of AKAN

AKANDA CORP (AKAN) Stock Price, Quote, News and Overview

NASDAQ:AKAN - Nasdaq - CA00971M4039 - Common Stock - Currency: USD

1.15  -0.03 (-2.54%)

AKAN Quote, Performance and Key Statistics

AKANDA CORP

NASDAQ:AKAN (4/25/2025, 8:00:00 PM)

1.15

-0.03 (-2.54%)

Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
Statistics
52 Week High47.52
52 Week Low0.93
Market Cap2.62M
Shares2.28M
Float1.09M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)12-13 2022-12-13/bmo
IPO03-15 2022-03-15


AKAN short term performance overview.The bars show the price performance of AKAN in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -10 -20 -30

AKAN long term performance overview.The bars show the price performance of AKAN in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of AKAN is 1.15 USD. In the past month the price decreased by -19.58%. In the past year, price decreased by -86.04%.

AKANDA CORP / AKAN Daily stock chart

AKAN Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 68.04 838.54B
JNJ JOHNSON & JOHNSON 15.38 372.51B
NVO NOVO-NORDISK A/S-SPONS ADR 17.94 275.58B
NVS NOVARTIS AG-SPONSORED ADR 14.12 221.49B
AZN ASTRAZENECA PLC-SPONS ADR 16.76 215.69B
MRK MERCK & CO. INC. 10.62 208.21B
PFE PFIZER INC 7.37 129.99B
SNY SANOFI-ADR 13.38 128.08B
BMY BRISTOL-MYERS SQUIBB CO 6.53 97.47B
GSK GSK PLC-SPON ADR 8.6 75.84B
ZTS ZOETIS INC 25.92 68.46B
TAK TAKEDA PHARMACEUTIC-SP ADR 31.98 47.30B

About AKAN

Company Profile

AKAN logo image Akanda Corp. is a cannabis cultivation, manufacturing, and distribution company, which engages in the provision of premium quality and ethically sourced medical cannabis products to patients. The Company’s portfolio includes Canmart Ltd. (CanMart), a United Kingdom-based fully licensed pharmaceutical importer and distributor which supplies pharmacies and clinics within the United Kingdom. Canmart is a licensed importer and distributor of CBD Extraction for Medicinal Purposes (CBPMs) in the United Kingdom. CanMart holds a controlled drug license issued by the Home Office to possess and supply CBPMs in the United Kingdom. The firm's seed-to-patient supply chain also includes partnerships Cellen Life Sciences' Leva Clinic, a fully digital pain clinic in the United Kingdom. The firm also develops a Canadian farming property in British Columbia, including farming land and related operations and licenses. The firm also focuses on developing tetrahydrocannabinol (THC) and cannabinoid (CBD) facilities at this site.

Company Info

AKANDA CORP

1A, 1B Learoyd Road

New Romney GB

Employees: 107

Company Website: https://akandacorp.com/

Investor Relations: https://www.akandacorp.com/investors/

Phone: 442034889514

AKANDA CORP / AKAN FAQ

What is the stock price of AKANDA CORP today?

The current stock price of AKAN is 1.15 USD. The price decreased by -2.54% in the last trading session.


What is the ticker symbol for AKANDA CORP stock?

The exchange symbol of AKANDA CORP is AKAN and it is listed on the Nasdaq exchange.


On which exchange is AKAN stock listed?

AKAN stock is listed on the Nasdaq exchange.


What is AKANDA CORP worth?

AKANDA CORP (AKAN) has a market capitalization of 2.62M USD. This makes AKAN a Nano Cap stock.


How many employees does AKANDA CORP have?

AKANDA CORP (AKAN) currently has 107 employees.


What are the support and resistance levels for AKANDA CORP (AKAN) stock?

AKANDA CORP (AKAN) has a resistance level at 1.16. Check the full technical report for a detailed analysis of AKAN support and resistance levels.


Should I buy AKANDA CORP (AKAN) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does AKANDA CORP (AKAN) stock pay dividends?

AKAN does not pay a dividend.


When does AKANDA CORP (AKAN) report earnings?

AKANDA CORP (AKAN) will report earnings on 2022-12-13, before the market open.


What is the Price/Earnings (PE) ratio of AKANDA CORP (AKAN)?

AKANDA CORP (AKAN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-286.63).


What is the Short Interest ratio of AKANDA CORP (AKAN) stock?

The outstanding short interest for AKANDA CORP (AKAN) is 4.1% of its float. Check the ownership tab for more information on the AKAN short interest.


AKAN Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

AKAN Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to AKAN. Both the profitability and financial health of AKAN have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

AKAN Financial Highlights

Over the last trailing twelve months AKAN reported a non-GAAP Earnings per Share(EPS) of -286.63. The EPS decreased by -83.91% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -323.87%
ROE -706.22%
Debt/Equity 0.08
Chartmill High Growth Momentum
EPS Q2Q%95.13%
Sales Q2Q%270.63%
EPS 1Y (TTM)-83.91%
Revenue 1Y (TTM)-17.54%

AKAN Ownership and Analysts


Ownership
Inst Owners1.35%
Ins OwnersN/A
Short Float %4.1%
Short Ratio1.46
Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A